Literature DB >> 688250

A single dose of metoclopramide in the control of vomiting from cis-dichlorodiammineplatinum(II) in man.

T Kahn, E G Elias, G R Mason.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 688250

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  7 in total

1.  Pronounced antiemetic activity of the antipsychotic drug levomepromacine (L) in patients receiving cancer chemotherapy.

Authors:  M Higi; N Niederle; W Bierbaum; C G Schmidt; S Seeber
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

2.  A randomised cross-over trial comparing low-dose metoclopramide and chlorpromazine with high-dose metoclopramide in Chinese patients with advanced cancer receiving cisplatinum and 5-fluorouracil.

Authors:  W Shiu; V Tsang; Y M Lam; A Zacharia; W M Martin
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  High-dose dexamethasone for prevention of cis-platin-induced vomiting.

Authors:  M S Aapro; D S Alberts
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

4.  Vincristine, Adriamycin, cyclophosphamide, and etoposide (VP16-213) in small-cell anaplastic carcinoma of the lung.

Authors:  F E von Eyben; A Arwidi; C Hellekant; K Jonsson; S A Lindahl; W Mattsson; L Tennvall
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

5.  Metoclopramide. A review of antiemetic trials.

Authors:  R J Gralla
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

Review 6.  Metoclopramide. An updated review of its pharmacological properties and clinical use.

Authors:  R A Harrington; C W Hamilton; R N Brogden; J A Linkewich; J A Romankiewicz; R C Heel
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

7.  An effective five-drug antiemetic combination for prevention of chemotherapy-related nausea and vomiting. Experience in eighty-four patients.

Authors:  J F Kessler; D S Alberts; P M Plezia; V Wilson; J Chase; M Aapro; E A Surwit
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.